Search Results - "Mentha, G"

Liver Transplantation for Hepatocellular Carcinoma: Five Steps to Prevent Recurrence by Toso, C., Mentha, G., Majno, P.

“…Liver transplantation is the best treatment of patients with unresectable early hepatocellular carcinoma, allowing disease‐free survival rates of 60–80% at 5…”
Get full text

PG 7.1 Liver First Approach in synchronous liver metastases from colorectal cancer by Mentha, G

Get full text

KRAS status and outcome of liver resection after neoadjuvant chemotherapy including bevacizumab (Br J Surg 2012; 99: 1575-1582) by Mentha, G.

“…Important predictor of survival…”
Get full text

Surgical management of patients with colorectal cancer and simultaneous liver and lung metastases by Andres, A., Mentha, G., Adam, R., Gerstel, E., Skipenko, O. G., Barroso, E., Lopez-Ben, S., Hubert, C., Majno, P. E., Toso, C.

“…Background The management of patients with colorectal cancer and simultaneously diagnosed liver and lung metastases (SLLM) remains controversial. Methods The…”
Get full text

Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary by Mentha, G., Majno, P. E., Andres, A., Rubbia-Brandt, L., Morel, P., Roth, A. D.

“…Background: In many patients with advanced synchronous liver metastases from colorectal tumours, the metastases progress during treatment of the primary,…”
Get full text

Toward a Better Liver Graft Allocation That Accounts for Candidates With and Without Hepatocellular Carcinoma by Toso, C., Mazzaferro, V., Bruix, J., Freeman, R., Mentha, G., Majno, P.

“…In some countries where the Model for End‐Stage Liver Disease (MELD) score is used for graft allocation, selected patients with hepatocellular carcinoma (HCC)…”
Get full text

Donor characteristics and risk of hepatocellular carcinoma recurrence after liver transplantation by Orci, L. A., Berney, T., Majno, P. E., Lacotte, S., Oldani, G., Morel, P., Mentha, G., Toso, C.

“…Background To date, studies assessing the risk of post‐transplant hepatocellular carcinoma (HCC) recurrence have focused on tumour characteristics. This study…”
Get full text

Systematic review and meta-analysis of the effect of perioperative steroids on ischaemia-reperfusion injury and surgical stress response in patients undergoing liver resection by Orci, L. A., Toso, C., Mentha, G., Morel, P., Majno, P. E.

“…Background Several therapeutic strategies, such as ischaemic preconditioning, intermittent or selective pedicle clamping and pharmacological interventions,…”
Get full text

Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery by Rubbia-Brandt, L., Giostra, E., Brezault, C., Roth, A.D., Andres, A., Audard, V., Sartoretti, P., Dousset, B., Majno, P.E., Soubrane, O., Chaussade, S., Mentha, G., Terris, B.

“…Background: The purpose of the study was to characterize histological response to chemotherapy of hepatic colorectal metastases (HCRM), evaluate efficacy of…”
Get full text

Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer by Rubbia-Brandt, L., Audard, V., Sartoretti, P., Roth, A. D., Brezault, C., Le Charpentier, M., Dousset, B., Morel, P., Soubrane, O., Chaussade, S., Mentha, G., Terris, B.

“…Background: In advanced metastatic colorectal adenocarcinoma, the addition of a neo-adjuvant systemic treatment to surgery might translate into a survival…”
Get full text

Liver resection in patients with eight or more colorectal liver metastases by Viganò, L., Capussotti, L., Majno, P., Toso, C., Ferrero, A., De Rosa, G., Rubbia-Brandt, L., Mentha, G.

“…Background Patients with large numbers of colorectal liver metastases (CRLMs) are potential candidates for resection, but the benefit from surgery is unclear…”
Get full text

Dangerous halo after neoadjuvant chemotherapy and two-step hepatectomy for colorectal liver metastases by Mentha, G., Terraz, S., Morel, P., Andres, A., Giostra, E., Roth, A., Rubbia-Brandt, L., Majno, P.

“…Background: Bilobar colorectal metastases are a therapeutic challenge and require a multidisciplinary approach. The aim of this study was to describe the…”
Get full text

Hepatopulmonary Syndrome Increases the Postoperative Mortality Rate Following Liver Transplantation: A Prospective Study in 90 Patients by Schiffer, E., Majno, P., Mentha, G., Giostra, E., Burri, H., Klopfenstein, C. E., Beaussier, M., Morel, P., Hadengue, A., Pastor, C. M.

“…Hepatopulmonary syndrome (HPS) is a frequent pulmonary complication of patients with end‐stage liver diseases. HPS is diagnosed by hypoxemia and pulmonary…”
Get full text

O130 DONOR CHARACTERISTICS AND THE RISK OF HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION by Orci, L.A, Combescure, C, Majno, P.E, Berney, T, Oldani, G, Morel, P, Mentha, G, Toso, C

Get full text

Treatment strategies for the management of advanced colorectal liver metastases detected synchronously with the primary tumour by Mentha, G, Majno, P, Terraz, S, Rubbia-Brandt, L, Gervaz, P, Andres, A, Allal, A.S, Morel, Ph, Roth, A.D

“…Abstract The review summarises the contributions of chemotherapy, interventional radiology and surgery to the improved survival observed in patients with…”
Get full text

Role of laparoscopic approach in colorectal liver metastasis. An international multi-center data analysis using LiverMetSurvey by Eveno, C, Cailliez, V, Lopezben, S, Mirza, D.F, Kaiser, G, Lapointe, R, Mentha, G, Pardo, F, Adam, R, Cherqui, D

Get full text

Improved liver function after portal vein embolization and an elective right hepatectomy by Meier, R, Toso, C, Terraz, S, Breguet, R, Berney, T, Andres, A, Jannot, A.-S, Rubbia-Brandt, L, Morel, P, Mentha, G, Majno, P

Get full text

226 A MODEL FOR DROPOUT ASSESSMENT OF CANDIDATES WITH OR WITHOUT HEPATOCELLULAR CARCINOMA ON A COMMON LIVER TRANSPLANT WAITING LIST by Toso, C, Dupuis-Lozeron, E, Majno, P, Berney, T, Kneteman, N, Perneger, T, Morel, P, Mentha, G, Combescure, C

Get full text

174 A SCORE PREDICTING SURVIVAL AFTER RETRANSPLANTATION FOR HEPATITIS C VIRUS CIRRHOSIS by Andres, A, Gerstel, E, Combescure, C, Asthana, S, Merani, S, Berney, T, Morel, P, Kneteman, N, Mentha, G, Toso, C

Get full text

Oxaliplatin combined with irinotecan and 5-fluorouracil/leucovorin (OCFL) in metastatic colorectal cancer: a phase I–II study by Seium, Y., Stupp, R., Ruhstaller, T., Gervaz, P., Mentha, G., Philippe, M., Allal, A., Trembleau, C., Bauer, J., Morant, R., Roth, A. D.

“…Background:: A phase I–II multicenter trial was conducted to define the maximal tolerated dose and describe the activity of an OCFL combination using…”
Get full text